Gregory T. Everson, MD, FACP
Professor of Medicine
Director, Section of Hepatology
Director, Section of Hepatology
Education
- Medical School: Cornell University Medical College
- Internship/Residency: 1976- 1979, Creighton University
- Fellowship: 1979-1982, University of Colorado School of Medicine
Honors and Awards
- Phi Beta Kappa
- National Institutes of Health Clinical Investigator Award, 1983 1986
- American Gastroenterological Association Research Award, 1983 1984
- American College of Physicians Teaching & Research Scholarship, 1983 1986
- Polycystic Kidney Research Foundation, Research Award, 1992-1993
- Best Doctors in America Award, 1999
- Fellow, American College of Physicians (FACP), 1999
Faculty Appointments
- 1982 to 1988 - Assistant Professor of Medicine, Division of Gastroenterology, University of Colorado School of Medicine, Denver, Colorado
- 1988 to 1996 - Associate Professor of Medicine, Division of Gastroenterology, University of Colorado School of Medicine, Denver, Colorado
- 1988 to 1995 - Director, Gastroenterology Fellowship Training Program, Core Director, GC/MS Laboratory, Hepatobiliary Research Center
- 1996 to Present - Professor of Medicine, Division of Gastroenterology, University of Colorado School of Medicine, Denver, Colorado
- 1990 to Present - Director, Section of Hepatology, University of Colorado School of Medicine, Denver, CO
Committees and Responsibilities
- 1992 - Present Training and Education Committee of the AASLD
- 1995 - Present Member of the Data and Safety Monitoring Board for the PBC Ursodiol Methotrexate Placebo Study (DSMB /PUMPS)
- 1996 - Present Board Member, American Liver Foundation
- 1999 - Present Co-Chair, Ancillary Committee, NIH-NIDDK 98-4 Hepatitis C Clinical Trial
- 1999 - Present Steering Committee, NIH, HALT-C Clinical Trial
- 2000 - Present Exemption Committee, NIH, HALT-C Clinical Trial
- 2000 - Present Recruitment Committee, NIH, HALT-C Clinical Trial
- 2002 - Present Clinical Outcomes Committee, NIH, HALT-C Clinical Trial
- 1999 - Present Hepatitis C Caring Ambassadors
- 1996 - Present Executive Board Member, American Liver
- 2002 - Present American Society of Transplantation Awards Committee
- 1997 - Present Chairman, Transplant Outcomes Committee
- 1998 - Present Member of the Clinical Practice Committee
- 1996 - Present Chairman, Association of Transplant Physicians and Surgeons
- 1999 - Present Faculty Committee to Review Infrastructure Support for Clinical Research
- 1991 - Present Chairman, Patient Selection Committee for Liver Transplantation
Research Interests
Dr. Everson's Lab laboratory is interested in new and emerging therapies for the treatment of chronic hepatitis C and chronic hepatitis B as well as interests in Hepatitis C/HIV Co-infections.
Representative Publications
- Everson GT. Should we treat patients with chronic hepatitis C on the waiting list? Journal of Hepatology 2005; April 42(4):456-62. (download PDF)
- Everson GT. Management of cirrhosis due to chronic hepatitis C. Journal of Hepatology 42 (2005) S65-S74. (download PDF)
- Everson GT. De Novo Hepatocellular Carcinoma in a Patient with Chronic Hepatitis C Five Years After Sustained Virologic Response to Interferon/Ribavirin Therapy. Digestive Diseases and Sciences 2005. (download PDF)
- Everson GT, Taylor M, Doctor RB. Polycystic Disease of the Liver. Hepatology 2004 Oct 40 (4): 774-7824. (download PDF)
- Everson GT. Management of Polycystic Liver Disease. Current Gastroenterology Reports; 2005 Feb; 7(1):19-25.
- Everson GT. Treatment of chronic hepatitis C in patients with decompensated cirrhosis. Rev Gastroenterol Disord 2004; 4 Suppl 1:S31-8